Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) affects RhoA activation in endothelial cells

Journal of Cellular Physiology

Volumn 211, Issue 3, 2007, Pages 708-715

  Suzuki, Takahiro ^a,b   Abe, Mayumi ^a,c   Miyashita, Hiroki ^a   Kobayashi, Toshimitsu ^b   Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOL AMINOPEPTIDASE; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; MUTANT PROTEIN; PROTEIN PILSAP; PROTEINASE ACTIVATED RECEPTOR; PUROMYCIN; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRESS FIBER;

ACTINS; ANIMALS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; LEUCYL AMINOPEPTIDASE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, G-PROTEIN-COUPLED; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SPLEEN;

EID: 34247602942     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20980     Document Type: Article

References (42)

1. Akada T, Yamazaki T, Miyashita H, Niizeki O, Abe M, Sato A, Satomi S, Sato Y. 2002. Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins. J Cell Physiol 193:253-262.
2. Alblas J, Ulfman L, Hordijk P, Koenderman L. 2001. Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12:2137-2145.
3. Altenbach C, Yang K, Farrens DL, Farahbakhsh ZT, Khorana HG, Hubbell WL 1996. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study. Biochemistry 35:12470-12478.
4. Barnes JA, Singh S, Gomes AV. 2004. Protease activated receptors in cardiovascular function and disease. Mol Cell Biochem 263:227-239.
5. Bourne HR. 1997. How receptors talk to trimeric G proteins. Curr Opin Cell Biol 9:134-142.
6. Brass LF, Molino M. 1997. Protease-activated G protein-coupled receptors on human platelets and endothelial cells. Thromb Haemost 78:234-241.
7. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569-571.
8. Collo G, Pepper MS. 1999. Endothelium cell integrin α5β1 expression is modulated by cytokines and during migration in vitro. J Biol Chem 270:26931-26939.
9. Cottrell GS, Coelho AM, Bunnett NW. 2002. Protease-activated receptors: The role of cell-surface proteolysis in signaling. Essays Biochem 38:169-183.
10. Danen EH, van Rheenen J, Franken W, Huveneers S, Sonneveld P, Jalink K, Sonnenberg A. 2005. Integrins control motile strategy through a Rho-cofilin pathway. J Cell Biol 169:515-526.
11. Dohlman HG, Caron MG, Lefkowits RJ. 1987. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 26:2657-2664.
12. Donovan S, Shannon KM, Bollag G. 2002. GTPase activation proteins: Critical regulators of intracellular signaling. Biochem Biophys Acta 1602:23-45.
13. Doughman RL, Firestone AJ, Wojtasiak ML, Bunce MW, Anderson RA. 2003. Membrane ruffling requires coordination between type I alpha phosphatidylinositol phosphate kinase and Rac signaling. J Biol Chem 278:23036-23045.
14. Fukuhara S, Chikumi H, Gutkind JS. 2001. RGS-containing RhoGEFs: The missing link between transforming G proteins and Rho? Oncogene 20:1661-1668.
15. Hart MJ, Sharma S, elMasry N, Qiu RG, McCabe P, Polakis P, Bollag G. 1996. Identification of a novel guanine nucleotide exchanging factor for the Rho GTPase. j Biol Chem 271:25452-25458.
16. Hoang MV, Whelan MC, Senger DR. 2004. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci USA 17:1874-1879.
17. Holinstat M, Mehta D, Kozasa T, Minshall RD, Malik AB. 2003. Protein kinase Cα-induced p115 RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J Biol Chem 278:28793-28798.
18. Hooper NM. 1994. Families of zinc metalloproteases. FEBS Lett 354:1-6.
19. Iwasaka C, Tanaka K, Abe M, Sato Y. 1996. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169:522-531.
20. Karnoub AE, Symous M, Campbell SL, Der CJ. 2004. Molecular basis for Rho GTPase signaling specificity. Breast Cancer Res Theat 84:61-71.
21. Klarenbach SW, Chipiuk A, Nelson RC, Hollenberg MD, Murray AG. 2003. Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: The role of Rho-GTPases. Circ Res 92:272-278.
22. Lauffenburger DA, Horwitz AF. 1996. Cell migration: A physically integrated molecular process. Cell 84:359-369.
23. Li S, Huang NF, Hsu S. 2005. Mechanotransduction in endothelial cell migration. J Cell Biochem 96:1110-1126.
24. Minambres R, Guasch RM, Perez-Arago A, Guerri C. 2006. The RhoA/ROCK-1/MLC pathway is involved in the ethanol-induced apoptosis by anoikis in astrocytes. J Cell Sci 119:271-282.
25. Miyashita H, Yamazaki T, Akada T, Niizeki O, Ogawa M, Nishikawa S, Sato Y. 2002. A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood 99:3241-3249.
26. Niizeki O, Miyashita H, Yamasaki T, Akada T, Abe M, Yoshida N, Watanabe T, Yoshimatsu H, Sato Y. 2004. Transcriptional regulation of angiogenesis-related puromycin-insensitive leucyl-specific aminopeptidase in endothelial cells. Arch Biochem Biophys 424:63-71.
27. Nobes CD, Hall A. 1999. Rho GTPase control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144:1235-1244.
28. Oda N, Abe M, Sato Y. 1999. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3. J Cell Physiol 178:121-132.
29. Panetti TS. 2002. Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochem Biophys Acta 1582:190-196.
30. Raftopoulou M, Hall A. 2004. Cell migration: Rho GTPases lead the way. Dev Biol 265:23-32.
31. Rossman KL, Der CJ, Sondek J. 2005. GEF means go: Turning of RHO GTPase with guanine nucleotide-exchanging factors. Nat Rev Mol Cell Biol 6:167-180.
32. Schmidt A, Hall A. 2002. Guanine nucleotide exchange factors for Rho GTPases: Turning on the switch. Gene Dev 16:1587-1609.
33. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419:480-483.
34. Sheetz MP, Felsenfeld DP, Galbraith CG. 1998. Cell migration: Regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol 8:51-54.
35. Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, Abe M, Moriya T, Ohta H, Sonoda H, Shimosegawa T, Tabayashi K, Sato Y. 2006. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol 26:1051-1057.
36. Small JV, Stradal T, Vignal E, Rottner K. 2002. The lamellipodium: Where motility begins. Trends Cell Biol 12:112-120.
37. Symons M, Settleman J. 2000. Rho family GTPases: More than simple switches. Trends Cell Biol 10:415-419.
38. Taylor A. 1993. Aminopeptidases: Structure and function. FASEB J 7:290-298.
39. Vouret-Craviari V, Grall D, Van Obberghen-Schilling E. 2003. Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J Thromb Haemost 5:1103-1111.
40. WessJ. 1997. G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11:346-354.
41. Yamazaki T, Akada T, Niizeki O, Suzuki T, Miyashita H, Sato Y. 2004. Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis. Blood 104:2345-2352.
42. Yanai N, Satoh T, Obinata M. 1991. Endothelial cells create a hematopoietic inductive microenvironment preferential to erythropoiesis in the mouse spleen. Cell Struct Funct 16:87-93.